ArticleBMJ neurology open2026
Predicting cancer aetiology in patients with stroke using brain imaging alone.
Article in BMJ neurology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ischaemic stroke due to cancer is becoming more common with high mortality rate. There is an unmet need to predict cancer aetiology in patients with stroke using brain imaging alone, to facilitate early diagnosis and treatment. Aims: To describe unique brain imaging patterns of cancer-related stroke and thereby develop a predictive model for diagnosis of stroke due to cancer. Our hypothesis was that such imaging patterns would be more closely associated with metastatic cancer. Methods: Retrospective cohort study at two neighbouring sites in Australia from 2014 to 2022. The cohort group included patients with acute ischaemic stroke due to active cancer. The control group consisted of conventional stroke aetiologies and no active cancer diagnosis. Brain imaging using MRI diffusion-weighted imaging sequences classified lesions by distribution, vascular territories, lesion number and whether multifocal, crossed territories or scattered. Statistical analysis used adjusted logistic regression models. Machine learning-based predictive modelling evaluated the predictive capacity on a diagnosis of metastatic cancer. Results: There were 138 patients available for analysis. A three-territory sign was the only significant imaging predictor for cancer aetiology in the multivariable analysis (OR 20.79; 95% CI 2.44 to 177.47, p=0.006). In the machine learning modelling, both logistic regression and support vector machines models predicted the presence of metastatic cancer well with a balanced accuracy of 75% and 79%, respectively, and area under the curve (receiver operating characteristic area) scores of 0.85 and 0.87, respectively. Conclusions: Brain imaging alone might potentially predict cancer aetiology with good accuracy in patients with stroke, especially in metastatic cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.